Phase I Clinical Study of Three Times a Day Oral Administration of TAS-102 in Patients with Solid Tumors

Author: Overman Michael   Kopetz Scott   Varadhachary Gauri   Fukushima Masakazu   Kuwata Keizo   Mita Akira   Wolff Robert   Hoff Paulo   Xiong Henry   Abbruzzese James  

Publisher: Informa Healthcare

ISSN: 0735-7907

Source: Cancer Investigation, Vol.26, Iss.8, 2008-10, pp. : 794-799

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content